tiprankstipranks
BioCryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market
Want to see BCRX full AI Analyst Report?

BioCryst (BCRX) Ownership - Who Owns BioCryst?

2,766 Followers

BioCryst (BCRX) Ownership Overview

1.47%15.39%39.17%19.89%24.08%
39.17% Other Institutional Investors
19.89% ETFs
24.08% Public Companies and Individual Investors
The ownership structure of BioCryst (BCRX) stock is a mix of institutional, retail, and individual investors. Approximately 74.45% of the company’s stock is owned by Institutional Investors, 1.47% is owned by Insiders, and 24.08% is owned by Public Companies and Individual Investors.
The ownership structure of BioCryst (BCRX) stock is a mix of institutional, retail, and individual investors. Approximately 54.56% of the company’s stock is owned by Institutional Investors, 1.47% is owned by Insiders, and 19.89% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
May 19, 2026
xxxxxxxxxxxxx
$100285
Mar 24, 2026
xxxxxxxxxxxxx
$504823
Dec 03, 2025
xxxxxxxxxxxxx
$367032
Aug 15, 2025
xxxxxxxxxxxxx
$595700

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
17,831,654Institution6.98%172,253,778
15,827,186Institution6.19%152,890,617
15,212,536Institution5.95%146,953,098
15,096,403Institution5.91%145,831,253
11,996,935Institution4.69%115,890,392
10,759,579Institution4.21%103,937,533
10,308,888Institution4.03%99,583,858
4,165,441Institution1.63%40,238,160
2,999,553Institution1.17%28,975,682
2,822,727Institution1.10%27,267,543

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
15,212,536Institution5.95%146,953,098
4,165,441Institution1.63%40,238,160
2,999,553Institution1.17%28,975,682
2,453,361Institution0.96%23,699,467
2,380,656Institution0.93%22,997,137
1,678,161Institution0.66%16,211,035
1,387,161Institution0.54%13,399,975
1,341,254Institution0.52%12,956,514
1,057,767Institution0.41%10,218,029
999,613Institution0.39%9,656,262

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
9,825,221Institution3.84%98,939,975
8,107,406Institution3.17%72,804,506
5,978,731Institution2.34%57,754,541
2,922,024Institution1.14%29,220,240
2,842,258Institution1.11%25,523,477
2,143,726Institution0.84%20,708,393
1,698,922Institution0.66%15,256,320
1,608,887Institution0.63%15,541,848
1,306,477Institution0.51%11,732,163
1,174,944Institution0.46%11,831,686

FAQ

Who Owns BioCryst Pharmaceuticals (BCRX)?
According to the latest TipRanks data, approximately 39.17% of the company's stock is held by institutional investors, 1.47% is held by insiders, and 24.08% is held by retail investors.
    What percentage of BioCryst Pharmaceuticals (BCRX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 39.17% of BioCryst Pharmaceuticals (BCRX) stock is held by institutional investors.
      What percentage of BioCryst Pharmaceuticals (BCRX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 24.08% of BioCryst Pharmaceuticals (BCRX) stock is held by retail investors.
        Who owns the most shares of BioCryst Pharmaceuticals (BCRX)?
        Vanguard owns the most shares of BioCryst Pharmaceuticals (BCRX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.